SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (16)4/10/2000 1:33:00 AM
From: johnsto1  Read Replies (1) | Respond to of 368
 
was just curious. seems their will be some ipo's in this sector worth investing in near future.
spent saturday by the pool reading aprils newsweeks 7 articles on this sector,probably no where near your fellas level but gave me some what of a foundation to build off,i'm going to read through them and more and wait for the light to come on a sector with in the sector before i invest-it usually comes.



To: scaram(o)uche who wrote (16)4/10/2000 2:00:00 PM
From: loonalone  Read Replies (3) | Respond to of 368
 
Does anyody with scientific background on this thread have an explanation of if (and if so, and how) Aria's ARGENT and RAPIDcompete/don't compete with SGMO's ZFP regulation technology? Is this a marketing/positioning/partnering space or is it a pure patent space? Is there a biological explanation for whether or not there may or may not be competing platforms? Need to know. Thanks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News